Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
PreprintLicence not statedChemRxiv

Ligand-Based Design of Lyn-Selective Type II Kinase Inhibitors by Rational Tail Modification of Imatinib

  • Avi L. Benitah1,2
  • Hadi H. Choudhary3,4,5
  • Khalid Hanafy3,4,5
  • Timothy I Richardson1,2,6,7
  • Pathum M. Weerawarna1,2
7 affiliations
  1. 1Department of Medicine, Division of Clinical Pharmacology
  2. 2Indiana University School of Medicine
  3. 3Department of Neurology
  4. 4Cooper University Health Care
  5. 5Cooper Medical School of Rowan University
  6. 6Stark Neurosciences Research Institute
  7. 7Indiana Biosciences Research Institute
Open at sourceDOICite

Related

  1. DprE1 inhibitors in tuberculosis: integrating structural binding determinants, IC50–MIC translation, and physicochemical constraints for rational drug design
    Fady H. Fayek, Mai H. A. Mousa, Mona F. Said +2
    RSC Medicinal ChemistryPeer-reviewedPublisher termsFull textMedicinal chemistry & drug discoveryPMC
  2. Functionalization of strong C(sp3)–H bonds in the presence of weak C(sp3)–H bonds enables the block-selective modification of thermoplastic elastomers
    Alexandra D. Handlin, Mark A. Nosiglia, Erik J. Alexanian +1
    Chemical sciencePeer-reviewedCC BY-NCFull textOrganic chemistryEurope PMC
  3. Physicochemical and Structural Determinants of BACE1-Selective Inhibition: An Integrative Modeling Study using A Combined Ligand-and Structure-Based Approach
    Marion Nabeneza-Lauret, Taher Yacoub, Roy González-Alemán +3
    ChemRxivPreprintCC BYGeneral chemistryChemRxiv
  4. Heme-Binding Groups in Cytochrome P450 Inhibitors: Coordination Mechanisms, Evidence Standards and Implications for CYP19A1 Ligand Design
    Paweł Kozyra, Maciej Masłyk
    MoleculesPeer-reviewedCC BY 4.0Full textInorganic & organometallic chemistryCrossrefEurope PMC
  5. Transforming Unidirectional CO2 to CO Reduction Catalysis into a Bidirectional One via Rational Ligand Engineering
    Chandan Das, Tejender Singh, Girish Mishra +7
    ChemRxivPreprintCC BYFull textGeneral chemistryChemRxiv

Cite

BibTeXRIS
BibTeX
@misc{benitah2026ligandbased,
  title = {{Ligand-Based Design of Lyn-Selective Type II Kinase Inhibitors by Rational Tail Modification of Imatinib}},
  author = {Avi L. Benitah and Hadi H. Choudhary and Khalid Hanafy and Timothy I Richardson and Pathum M. Weerawarna},
  howpublished = {ChemRxiv},
  year = {2026},
  month = oct,
  doi = {10.26434/chemrxiv.15011338/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011338/v1},
}
RIS
TY  - UNPB
TI  - Ligand-Based Design of Lyn-Selective Type II Kinase Inhibitors by Rational Tail Modification of Imatinib
AU  - Avi L. Benitah
AU  - Hadi H. Choudhary
AU  - Khalid Hanafy
AU  - Timothy I Richardson
AU  - Pathum M. Weerawarna
PY  - 2026
DA  - 2026/10/30
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15011338/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011338/v1
ER  -